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DURING PREGNANCY many women in
Australia routinely have urinalysis.
However, there appears to be little evi-
dence to support this practice.1,  There
is understandable concern about ceas-
ing urinalysis in pregnant women with-
out evidence for the benefit or safety of
this change, particularly for those who
may develop proteinuria before hyper-
tension. Thus, an important question is:
can urine testing in pregnancy be elimi-
nated without delaying the diagnosis of
pre-eclampsia?
We determined whether routine urinaly-
sis during pregnancy should be continued
in women with normal results of both
urinalysis and microscopic examination




We used a prospective observational study
design. From March to November 1999,
all pregnant women attending a hospital
antenatal care unit were asked to partici-
pate in the study at their initial antenatal
visit, and the study was explained verbally
and in writing before their written consent
was obtained. Nine hundred women from
the public hospital antenatal service and
100 women from a nearby private hospital
were enrolled in the study. Eighty-seven
women were lost to follow-up (miscar-
riage, relocation or withdrawal from the
study for personal reasons), leaving 913
women in the study sample.
Procedure for urinalysis
At the first antenatal visit, a urine sam-
ple was collected for dipstick urinalysis,
microscopic examination and culture.
Women were given written and oral
instructions on the collection of a mid-
stream specimen of urine, including
perineal cleansing and avoiding skin
contact with the collection container.
Urine was collected at each subsequent
visit using the same procedure.
To perform the dipstick urinalysis,
we used Multistix 8SG test strips
(Bayer Diagnostics, Victoria, Aus-
tralia) and an automated urinalysis
device (Clinitek 50, Bayer). If pro-
teinuria was detected (1+ protein),
the specimen was sent to the laboratory
for a spot protein/creatinine ratio3 and,
if a urinary tract infection was sus-
pected (based on either clinical symp-
toms or the presence of nitrites and
leukocytes on dipstick urinalysis),
microscopic examination and culture
were performed.
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ABSTRACT
Objectives:  To determine whether routine urinalysis in the antenatal period 
facilitates diagnosis of pre-eclampsia. Can routine urinalysis during pregnancy be 
discontinued in women with normal results of dipstick urinalysis and microscopy at 
the first antenatal visit?
Design:  Prospective observational study.
Setting:  A metropolitan public hospital and a private hospital in Sydney (NSW).
Participants:  One thousand women were enrolled at their first antenatal visit 
(March to November 1999), and 913 completed the study.
Outcome measures:  The primary outcome was a diagnosis of de novo 
hypertension (gestational hypertension, pre-eclampsia, or pre-eclampsia 
superimposed on chronic hypertension).
Results:  Thirty-five women had dipstick proteinuria at their first antenatal visit. 
In 25 (71%) of these women, further dipstick proteinuria was detected during 
pregnancy, and two (6%) were diagnosed with pre-eclampsia. Of the 867 without 
dipstick proteinuria at the first visit, 338 (39%) had dipstick proteinuria (> 1+) at 
some time during pregnancy. There were no statistically significant differences in 
the proportion of women with and without dipstick proteinuria at their first visit who 
developed hypertension during pregnancy. Only six women developed proteinuria 
before the onset of hypertension. Women who had an abnormal result of a 
midstream urine test at their first visit, compared with women with a normal result, 
were more likely to have a urinary tract infection diagnosed during pregnancy; 
however, the numbers were small.
Conclusion:  In the absence of hypertension, routine urinalysis during pregnancy 
is a poor predictor of pre-eclampsia. Therefore, after an initial screening urinalysis, 
routine urinalysis could be eliminated from antenatal care without adverse outcomes 
MJA 2002; 177: 477-480
for women.
RESEARCH
478 MJA Vol 177 4 November 2002
RESEARCH
Screening for gestational diabetes
At the time of the study, all women in
our unit were screened for gestational
diabetes either at their first visit or at 28
week’ gestation using a 50 g oral glucose
challenge test. Women were screened
early if they had a history of gestational
diabetes, a strong family history of dia-
betes or glycosuria at the first visit.
Definitions
■ Dipstick proteinuria was defined as
1+ protein on the automated device.
■ A midstream urine sample was
classified as “normal” if it contained
<10  106/L erythrocytes, <10  106/
L polymorphs, and it was culture nega-
tive; and as “abnormal” if it contained a
pathogen and/or haematuria (erythro-
cytes >10  106/L).
■ A urinary tract infection was diag-
nosed when >106/L organisms were
cultured, with associated pyuria in the
absence of epithelial cells.
■ Blood pressure measurements
(using mercury sphygmomanometry)
were taken in accordance with the con-
sensus statement of the Australasian
Society for the Study of Hypertension.4
■ Hypertensive disorders of preg-
nancy. The definitions used were those
of the Australasian Society for the Study
of Hypertension in Pregnancy.5
Data collection
Demographic details, medical and
obstetric history were recorded for each
woman at the first antenatal visit. The
results of blood pressure measurement,
dipstick urinalysis and urine micro-
scopic examination and culture were
recorded. At each subsequent visit,
blood pressure and dipstick urinalysis
results were recorded.
The primary outcome was a diagnosis
of de novo hypertension (ie, gestational
hypertension, pre-eclampsia or pre-
eclampsia superimposed on chronic
hypertension).
Ethical approval
The study was approved by the Institu-
tional Ethics Committee of the South
Eastern Sydney Area Health Service
(Southern Section).
Statistical analysis
We determined the relationship
between first-visit dipstick proteinuria,
pregnancy outcomes and development
of hypertension during pregnancy. Clin-
ical outcomes of women who had “nor-
mal” versus “abnormal” urine at the
first visit and the outcomes of those who
subsequently developed proteinuria
were compared using 2 testing. Fisher’s
exact test was used when the number of
observations was less than five.
RESULTS
1.Results
The mean age of the 913 women was 29
years (range, 14–48 years) and 48%
(n=442) were nulliparous. Most (62%)
were from English-speaking back-
grounds. Nineteen per cent were from
Asian countries and 9% from Arabic-
speaking countries. The remaining 10%
came from European and South Ameri-
can countries. This cultural diversity is
representative of the population in the
southern suburbs of Sydney where the
study was conducted. There were no
differences in the demographic charac-
teristics of women in the study sample
compared with those who were lost to
follow-up (data not shown).
Six per cent (n=52) of women in the
study reported previous renal disease,
including recurrent urinary tract infec-
tion or pyelonephritis (n=28), renal cal-
culi (n=15) and haematuria (n=5), and
2% (n=18) had had essential hyperten-
sion. Of the 471 multiparous women,
11 per cent (n=50) reported previous
pre-eclampsia or gestational hyperten-
sion.
The flow chart (Box 1) summarises
the results of urinalysis in study partici-
pants at the first antenatal visit and
during pregnancy, as well as the out-
comes.
Urine tests at the first antenatal visit and 
subsequent hypertension
Eleven women did not have dipstick
urinalysis performed at their first visit,
although all 913 women had a urine
sample collected for microscopic exami-
nation and culture.
Thirty-five women had dipstick pro-
teinuria at their first visit, but only 14
had a specimen sent for a spot protein/
creatinine ratio. Of these 14, two had
true proteinuria (30 mg protein/mmol
creatinine). Four of the 35 women with
first-visit dipstick proteinuria had a his-
1: Flow chart of urinalysis detected during pregnancy, and outcomes
Women enrolled in study n = 1000
Lost to follow up n = 87





No dipstick proteinuria 
n = 867
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tory of renal disease. Further dipstick
proteinuria was detected during preg-
nancy in 25 of these 35 women (71%)
and two (6%) were diagnosed with pre-
eclampsia.
Of the 867 women without first-visit
dipstick proteinuria, 338 (39%) had
dipstick proteinuria (1+) at some time
during pregnancy. There were no statis-
tically significant differences in the pro-
portion of women with and without
first-visit dipstick proteinuria at their
first visit who developed hypertension
during pregnancy (Box 2A).
Proteinuria during pregnancy and 
pre-eclampsia
Of the 338 women (39%) who devel-
oped dipstick proteinuria during preg-
nancy, most (n = 325; 96%) had 1+
proteinuria, with 11 having 2+, and two
women 3+ proteinuria. Fifteen of the
338 women with dipstick proteinuria
(4%) developed pre-eclampsia, com-
pared with nine of the 529 women (2%)
without dipstick proteinuria during
pregnancy (Box 2B).
Thus, 24 women, who did not have
proteinuria at their first visit, developed
pre-eclampsia: six had proteinuria diag-
nosed before the development of hyper-
tension, six had proteinuria identified at
the same time as hypertension was diag-
nosed, and the remaining 12 women
developed proteinuria after the diagno-
sis of hypertension (Box 1).
Of the six women who developed
proteinuria (and ultimately pre-eclamp-
sia) before the onset of hypertension,
two had multiple pregnancies, one had a
history of pre-eclampsia, but none had a
history of renal disease. Five of the
women delivered at more than 36
weeks’ gestation, with the remaining
woman delivering at 32 weeks’ gesta-
tion. There were no adverse neonatal
outcomes.
Microscopic examination and culture 
of urine
All 913 women had a first-visit mid-
stream urine sample sent to the labora-
tory for microscopic examination and
culture: 91% (n=833) had a “normal”
result and 8% (n=80) an “abnormal”
result (Box 3). Most of the abnormal
results (97%) were related to the pres-
ence of red or white blood cells or sterile
pyuria.
Women who had an abnormal mid-
stream urine sample at their first visit
were more likely to have a urinary tract
infection diagnosed during pregnancy
compared with those with a normal
midstream urine sample; however, the
numbers were small. Four per cent of
women (n=3) with an abnormal mid-
stream urine sample developed a uri-
nary tract infection, compared with 1%
of women (n=7) with a normal mid-
stream urine sample (P <0.05; relative
risk, 4.5; 95% CI, 1.2–17).
DISCUSSION
1.Discussion
Our results show that routine urinalysis
during pregnancy is a poor predictor of
the development of pre-eclampsia. We
suggest that, after the initial screening
urinalysis, routine urine testing could be
eliminated from antenatal care in low-
risk women. Only six women in our
study had proteinuria diagnosed before
the development of hypertension, and
no adverse outcomes occurred in this
group. Of these six women, three could
be described as having risk-associated
pregnancies (multiple pregnancy, previ-
ous history of pre-eclampsia). There-
fore, even if routine urinalysis during
pregnancy was not part of antenatal
care for low-risk women, these three
women would have continued to have
urine tests during their pregnancies. In
practice, clinical intervention is not
instigated until  hyper tension is
2: Development of hypertension and pre-eclampsia
A: According to the result of dipstick urinalysis at the first antenatal visit (n = 902)*
No proteinuria Proteinuria† P‡
Relative risk 
(95%  CI)
n = 867 n = 35
No hypertension 809 (93%) 31 (89%) 0.2 1.8 (0.6–4.8)
Pre-eclampsia 24 (3%) 2 (6%)
Hypertension, other§ 34 (4%) 2 (6%)
B: In women with no proteinuria at the first antenatal visit (n = 867) who subsequently 
developed dipstick proteinuria during pregnancy
n = 529 n = 338
No hypertension 503 (95%) 306 (91%) 0.01 1.5 (1.1–1.9)
Pre-eclampsia 9 (2%) 15 (4%)
Hypertension, other§ 17 (3%) 16 (5%)
*Eleven women did not have dipstick urinalysis performed at their first visit. †Protein >1+ on dipstick 
urinalysis. ‡2 test for differences between groups. §Includes gestational hypertension, chronic 
hypertension, and pre-eclampsia superimposed on chronic hypertension.
3: Development of hypertension and subsequent urinary tract infection 








No hypertension 778 (93%) 73 (91%) 0.5 1.3 (0.6–2.8)
Hypertension
Pre-eclampsia 22 (3%) 4 (5%)
Gestational hypertension 21 (2%) 2 (2%)
Chronic hypertension 5 (1%) 1 (1%
Pre-eclampsia superimposed on 
chronic hypertension 
7 (1%) 0
Urinary tract infection during pregnancy 7 (1%) 3 (4%) 0.05 4.5 (1.2–17)
*Infection and/or haematuria. †2 tests for differences between groups; where number of observations <5, 
Fisher’s exact test was used.
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detected. The detection of proteinuria
may mean more intense clinical supervi-
sion; however, it is unlikely that cessa-
tion of routine urinalysis would have
jeopardised the outcomes in these six
women.
From previous research on routine
urinalysis in pregnancy, it was con-
cluded that, in low-risk women with no
objective signs of a hypertensive disor-
der, routine dipstick proteinuria screen-
ing at each antenatal visit does not
provide clinically important information
about pregnancy outcome.1 This
research, while useful, was limited by
including only women who had no evi-
dence of a hypertensive disorder
(including elevated blood pressure,
marked oedema and excessive weight
gain) during pregnancy. Recent Austral-
asian consensus guidelines do not
include the last two clinical features as
diagnostic or predictive of hypertensive
disorders of pregnancy.5 Gribble et al1
also excluded women with pre-existing
renal disease or chronic hypertension,
multiple pregnancy or proteinuria on
the initial urine test. We chose to
include all women within the study
period to ensure that the study sample
was representative of women seen in
routine antenatal care.
In clinical practice, routine urinalysis
in pregnancy is considered as being
useful in the diagnosis of gestational or
pre-existing diabetes. At the time of our
study, all women in our unit were
screened for gestational diabetes using
an oral glucose challenge test. Cur-
rently, our protocol for screening for
diabetes is in line with recommenda-
tions of the Australasian Diabetes in
Pregnancy Society.6 If routine urinalysis
during pregnancy were to be omitted,
these women would still be identified,
either because of glycosuria at the first
visit or a positive glucose screening test.
It has also been suggested that urinaly-
sis in pregnancy assists in the detection
of asymptomatic bacteriuria.7 We would
suggest that all women who have
“abnormal” results of an initial dipstick
urine test should have a midstream
urine sample sent for microscopic
examination and culture. This would
ensure that asymptomatic bacteriuria or
underlying renal disease in pregnant
women would be detected at their first
visit.
While our study protocol mandated
that all women with 1+ proteinuria on
dipstick testing should have the sample
sent to the laboratory for a spot protein/
creatinine ratio, this did not always
occur. This is regrettable, as we know
from our previous research that this
ratio is a valuable tool in diagnosis of
true proteinuria.3 Clearly, better educa-
tion of clinicians in the antenatal serv-
ices is necessary to ensure that, when
dipstick urine testing is done, appropri-
ate follow-up of abnormal results is
performed.
Clearly, randomised controlled trials
are the ideal study type to address ques-
tions of clinical practice such as those
posed in our study. However, as this was
not feasible, we conducted a prospective
observational study. The sample size
was selected on feasibility and practical-
ity grounds, and thus there is a potential
for a type II error (reporting no differ-
ence when indeed there may have been
a difference). We acknowledge this limi-
tation, but suggest that, in the circum-
stances, where units all over Australia
have different protocols for urine testing
in pregnancy, our study (which provides
Level 3 evidence) may provide some
clinical guidance for healthcare provid-
ers. A further limitation of our study is
that no adjustments were made for pos-
sible confounders. This was not per-
formed, as the numbers of women with
pre-eclampsia were too small.
CONCLUSIONS
1.Conclusions
■ All low-risk women should provide a
correctly collected midstream urine
sample at their first antenatal visit for an
automated dipstick urine test.
■ Women with normal results of an
initial dipstick urine test require no
further urine tests in pregnancy, unless
they develop hypertension or clinical
signs and/or symptoms of urinary tract
infection.
■ Women with abnormal results of a
dipstick urine test (including the pres-
ence of leukocytes, nitrites or blood)
should have a midstream urine sample
sent for microscopic examination, cul-
ture and sensitivity testing. If the result
is asymptomatic bacteriuria, this should
be treated appropriately. If the results
are normal, no further urine samples
are necessary, unless the woman devel-
ops hypertension or has symptoms and/
or signs of a urinary tract infection.
■ Women found to have true proteinu-
ria and/or haematuria at their first ante-
natal visit may have underlying renal
disease, which should be investigated.
■ Routine urinalysis should continue
for women with “at-risk” pregnancies
(eg, early increase in blood pressure
level, essential hypertension, renal dis-
ease), as the detection of pre-eclampsia
is important in this high-risk group.
More research is needed to determine
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